Search SciPol

Brought to you by
What it does 

S 1079, the Protecting Americans from Dangerous Opioids Act, would require the Food and Drug Administration (FDA) to revoke the approval of a previously-approved opioid drug if the FDA wishes to grant approval to a new opioid drug. To determine what drug's approval to revoke, the FDA must prioritize the revocation of opioid drugs lacking abuse deterrent formulations, and must consider the public health impact of having the new opioid drug on the market.

Status 

S 1079 was introduced in the Senate on May 9, 2017, and referred to the Committee on Health, Education, Labor, and Pensions on the same date.

Sponsors 

Sponsor: Senator Joe Manchin III (D-WV) 

License 
Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Please distribute widely but give credit to Duke SciPol and the primary author(s) listed above, linking back to this page if possible.